Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
3 Reliable Blue-Chip Stocks to Buy, Hold and Never Let Go
July 18, 2024
Load up your portfolio with the best blue-chip stocks to buy and hold and take home solid gains in the long-term.
Via
InvestorPlace
Will Eli Lilly Do a Stock Split in 2024?
July 18, 2024
Eli Lilly hasn't done a stock split in decades.
Via
The Motley Fool
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
July 17, 2024
These three wild-card stocks will spice up your portfolio in ways boring diversification never could, so read on.
Via
InvestorPlace
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
July 17, 2024
Roche has a new GLP-1 weight loss drug in the works -- and one very cheap stock.
Via
The Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
July 17, 2024
After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, Pfizer Inc (NYSE: PFE) moved forward with the once-daily version. On...
Via
Benzinga
Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
July 16, 2024
Via
Benzinga
Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
July 15, 2024
Via
Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996 trial results for type 2 diabetes and obesity. Get insights into the latest...
Via
Benzinga
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
July 17, 2024
Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run company Linde.
Via
Benzinga
3 Unstoppable Stocks That You Can Buy and Hold for Years
July 17, 2024
These blue chip stocks are leaders within their respective industries.
Via
The Motley Fool
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Roche released early-stage data on its oral weight-loss drug.
Via
Investor's Business Daily
Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
July 16, 2024
Novo Nordisk will meet with U.S. Senate aides to discuss the discontinuation of Levemir, its long-acting insulin, amid concerns about manufacturing constraints and patient access. Senators press for...
Via
Benzinga
3 Biotech Stocks to Buy in Case of Another Pandemic
July 16, 2024
These are three of the best biotech stocks to keep an eye on as the industry helps governments prepare for the next pandemic.
Via
InvestorPlace
How Should a Beginner Invest in Stocks? Try This Index Fund.
July 16, 2024
A single investment can immediately have you owning a chunk of 500 American companies. It can power a comfortable retirement, too.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
July 15, 2024
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's Q2 FY24 earnings report on August 8 will include a pre-tax IPR&D charge of...
Via
Benzinga
7 Top-Quality Stocks to Buy Now: July 2024
July 15, 2024
With plenty of uncertainties ahead, investors should look for top-quality stocks for the remainder of the year.
Via
InvestorPlace
Americans Are Flying; Airline Stocks Are Not
July 15, 2024
How the airline industry's focus on capacity and being able to supply more flights means fares are low, even in the face of record demand.
Via
The Motley Fool
2 Unstoppable Growth Stocks to Buy and Hold for the Next Decade
July 15, 2024
These elite companies can help you build lasting wealth.
Via
The Motley Fool
Positive News is Driving This Cancer Drug Maker’s Stock Higher
July 15, 2024
IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather
Via
MarketBeat
7 Billion-Dollar Stocks That Deserve a Spot in Your Portfolio
July 15, 2024
Accumulate these billion-dollar stocks before they hit a new high and march towards the trillion dollar status.
Via
InvestorPlace
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
July 15, 2024
Revenue is climbing at these two drug companies -- and the trend should continue.
Via
The Motley Fool
3 Stocks for Patient Investors Looking to Build Generational Wealth
July 14, 2024
Investing in generational wealth stocks means holding them for years, preferably decades, to allow them to deliver supercharged returns.
Via
InvestorPlace
2 High-Flying Growth Stocks You Can Buy Right Now Before They Surge Even Higher
July 14, 2024
Shares are up for very good reasons.
Via
The Motley Fool
2 Incredibly Cheap Growth Stocks to Buy Now
July 14, 2024
Price is just one factor to consider.
Via
The Motley Fool
Is Eli Lilly a Good Dividend Stock to Buy Now?
July 14, 2024
A leading anti-obesity treatment plus a new Alzheimer's drug could drive profits through the roof.
Via
The Motley Fool
This 1 Piece of Bad News for Novo Nordisk Is Good News for Eli Lilly Stock
July 14, 2024
A new study raises important implications regarding the competitive balance between these two companies.
Via
The Motley Fool
The 7 Most Important Stocks to Watch as Q2 Earnings Season Kicks Off
July 13, 2024
Seven Q2 earnings season stocks are powered by catalysts that could have a major impact on their companies fortunes.
Via
InvestorPlace
3 Powerful Stocks Worthy of Magnificent 7 Status
July 13, 2024
These Potential Magnificent 7 stocks have quite a run ahead and could challenge the original seven in the second half.
Via
InvestorPlace
MarketBeat Week in Review – 7/8 - 7/12
July 13, 2024
Stocks took investors on quite a ride this week, with the S&P 500 hitting a new record high, then falling back on Thursday before rallying to end the week
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
July 13, 2024
The news likely didn't come as a big surprise to investors.
Via
The Motley Fool
Exposures
Product Safety
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.